Category: Consumer goods
Industry: Drug Manufacturers - Major Quick infos Headquarters: Paris, France Trade prices Volume: 2.0M Market Cap: 127.39B Prev closed: Open: 52.31 High: 52.79 Low: 52.19 52 week low: 45.17 52 week high: 54.26 Dividends: Next ER: April 27, 2023 Before Market Opens
About the Company Sanofi S.A. is a French multinational healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.
Earnings History Date EPS / Forecast Revenue / Forecast July 28, 2023 April 27, 2023 2.16 / 1.8710.22B / 11.43BFebruary 3, 2023 1.71 / 0.9210.72B / 12.2BOctober 28, 2022 1.43 / 1.3113.07B / 12.98BBeat! July 28, 2022 0.8785 / 0.83910.27B / 10.12BBeat! view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:August 20, 2004 Employees:95,442 News
Sanofi's (SNY) Dupixent Meets Goal in Pivotal COPD Study finance.yahoo.com Mar 28, 2023 1:39 pm
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover finance.yahoo.com Mar 28, 2023 11:15 am
Regenerons Asthma Drug Results Were Stellar. Analyst Sees a Sales Bonanza. finance.yahoo.com Mar 28, 2023 9:17 am Sanofi stock rises as Dupixent shows benefit in lung disease smokers, meets phase 3 goals seekingalpha.com Mar 23, 2023 5:31 pm
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock? finance.yahoo.com Mar 28, 2023 8:43 am
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data finance.yahoo.com Mar 28, 2023 8:00 am
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly finance.yahoo.com Mar 28, 2023 7:41 am
Market Digest: SNY, SJM finance.yahoo.com Mar 28, 2023 7:11 am
Amgen-Sanofi patent case divides makers of antibody drugs finance.yahoo.com Mar 27, 2023 6:51 pm
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover finance.yahoo.com Mar 26, 2023 8:45 am
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7% finance.yahoo.com Mar 24, 2023 2:29 pm
Sanofi (SNY) Dips More Than Broader Markets: What You Should Know finance.yahoo.com Mar 23, 2023 6:00 pm
UPDATE 3-Sanofi to cut US price of its most-prescribed insulin by 78% finance.yahoo.com Mar 23, 2023 4:45 pm
Analyst Report: Sanofi finance.yahoo.com Mar 23, 2023 4:40 pm
Press Release: Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78% and caps out-of-pocket Lantus costs at $35 for all patients with commercial insurance finance.yahoo.com Mar 23, 2023 4:06 pm
Pfizer Agrees to Buy Seagen for $43 Billion finance.yahoo.com Mar 23, 2023 3:06 pm
Why Shares of Regeneron Are Rising Thursday finance.yahoo.com Mar 23, 2023 12:08 pm
UPDATE 4-U.S. FDA approves Sanofi's bleeding disorder therapy finance.yahoo.com Mar 23, 2023 11:56 am
Provention Bio Stock Soars on $2.9 Billion Acquisition by Sanofi finance.yahoo.com Mar 23, 2023 11:38 am
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline finance.yahoo.com Mar 23, 2023 11:35 am SNY Dividends Ex-Dividend Amount Announced Date Record Date Payment Date May 30, 2023 1.3773019 Jun 23, 2023 May 26, 2022 0.1766908 Jun 27, 2022 May 4, 2022 1.26013 May 31, 2022 May 3, 2021 1.3676566 May 26, 2021 Apr 30, 2020 1.1735676 May 26, 2020 view more
Key Persons CEO : Paul Hudson (1 Sep 2019–) Talk about Sanofi below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
